Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Arteriosclerosis D001161 86 associated lipids
Body Weight D001835 333 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Christiansen C et al. [Effects of natural estrogen/gestagen and thiazide on cardiovascular risk factors in normal menopausal women. A 2-year double-blind placebo study]. 1981 Ugeskr. Laeg. pmid:7303230
Nielsen JA [Jaundice following norethisterone plus mestranol (Plan)]. 1970 Ugeskr. Laeg. pmid:5487344
Andreasen EE et al. [Progesterone and gestagen treatment. Pharmacologic and clinical aspects]. 1989 Ugeskr. Laeg. pmid:2672497
Andreasen EE et al. [Absorption of norethisterone acetate from tablets with normal and coarse particle size]. 1989 Ugeskr. Laeg. pmid:2660374
Wiese J [Drug information. Mini-pills]. 1975 Ugeskr. Laeg. pmid:1154531
[Withdrawal of "high estrogenic" contraceptive pills]. 1974 Ugeskr. Laeg. pmid:4446083
Varini M et al. Treatment of advanced breast cancer with norethisterone acetate. 1979 Tumori pmid:543013
Sheen-Chen SM et al. Intratumoral hemorrhage of mammary phyllodes tumor after menstrual induction: a puzzling presentation. 2007 Nov-Dec Tumori pmid:18338504
Hapgood JP et al. Not all progestins are the same: implications for usage. 2004 Trends Pharmacol. Sci. pmid:15491776
WOOD JE and GOODRICH SM DILATION OF THE VEINS WITH PREGNANCY OR WITH ORAL CONTRACEPTIVE THERAPY. 1964 Trans. Am. Clin. Climatol. Assoc. pmid:14301914
Cowen PH Treatment of glaucoma with norethisterone. 1970 Trans Aust Coll Ophthalmol pmid:5525171
Yamasaki K et al. Immature rat uterotrophic assay of 18 chemicals and Hershberger assay of 30 chemicals. 2003 Toxicology pmid:12504345
Yamasaki K et al. Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. 2002 Toxicology pmid:11750080
Fan F et al. Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. 2015 Toxicol. Sci. pmid:25752796
Morgan RE et al. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. 2010 Toxicol. Sci. pmid:20829430
Schardein JL et al. Long-term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats. 1970 Toxicol. Appl. Pharmacol. pmid:5416742
Freudenthal RI et al. Metabolism and distribution of norethynodrel in pregnant and nonpregnant mice. 1973 Toxicol. Appl. Pharmacol. pmid:4686779
Cano-Nicolau J et al. Several synthetic progestins disrupt the glial cell specific-brain aromatase expression in developing zebra fish. 2016 Toxicol. Appl. Pharmacol. pmid:27245768
Yoshida T et al. Serum oxytocin concentrations in women under pseudopregnant therapy. 1982 Tohoku J. Exp. Med. pmid:7112555
YENEN E and MOSTAR S [EXPERIMENTS ON THE MECHANISM OF ACTION OF ORAL GESTAGENS]. 1963 Tip Fak Mecm pmid:14126607